Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.76
(-0.74%)
CNY 18.76
(-0.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 145.19 Million CNY | -97.14% |
| 2022 | 5.07 Billion CNY | 199.2% |
| 2021 | 1.69 Billion CNY | 201.95% |
| 2020 | 562.27 Million CNY | 1253.64% |
| 2019 | 41.53 Million CNY | -39.18% |
| 2018 | 68.29 Million CNY | -9.73% |
| 2017 | 75.66 Million CNY | 12.77% |
| 2016 | 67.09 Million CNY | 62.79% |
| 2015 | 41.21 Million CNY | 85.12% |
| 2014 | 22.26 Million CNY | 167.81% |
| 2013 | 8.31 Million CNY | 552.04% |
| 2012 | 1.27 Million CNY | 621.45% |
| 2011 | -244.51 Thousand CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -52.73 Million CNY | 28.88% |
| 2024 Q2 | -8.21 Million CNY | 84.42% |
| 2024 Q3 | -13.2 Million CNY | -60.73% |
| 2023 Q3 | 48.68 Million CNY | -33.2% |
| 2023 Q4 | -74.15 Million CNY | -252.31% |
| 2023 FY | 145.19 Million CNY | -97.14% |
| 2023 Q1 | 97.77 Million CNY | -73.91% |
| 2023 Q2 | 72.88 Million CNY | -25.46% |
| 2022 Q4 | 374.71 Million CNY | -72.15% |
| 2022 Q2 | 1.66 Billion CNY | -2.0% |
| 2022 Q1 | 1.69 Billion CNY | 254.25% |
| 2022 FY | 5.07 Billion CNY | 199.2% |
| 2022 Q3 | 1.34 Billion CNY | -19.09% |
| 2021 Q1 | 417 Million CNY | 213.43% |
| 2021 Q3 | 517.02 Million CNY | 81.53% |
| 2021 Q2 | 284.8 Million CNY | -31.7% |
| 2021 Q4 | 478.97 Million CNY | -7.36% |
| 2021 FY | 1.69 Billion CNY | 201.95% |
| 2020 Q2 | 238.31 Million CNY | 4442.65% |
| 2020 Q4 | 133.04 Million CNY | -28.35% |
| 2020 FY | 562.27 Million CNY | 1253.64% |
| 2020 Q1 | 5.24 Million CNY | 202.2% |
| 2020 Q3 | 185.67 Million CNY | -22.09% |
| 2019 Q2 | 23.14 Million CNY | 23.38% |
| 2019 Q1 | 18.75 Million CNY | 46.79% |
| 2019 FY | 41.53 Million CNY | -39.18% |
| 2019 Q4 | -5.13 Million CNY | -207.69% |
| 2019 Q3 | 4.76 Million CNY | -79.41% |
| 2018 Q2 | 29.9 Million CNY | 82.29% |
| 2018 Q1 | 16.4 Million CNY | -33.01% |
| 2018 FY | 68.29 Million CNY | -9.73% |
| 2018 Q4 | 12.78 Million CNY | 38.77% |
| 2018 Q3 | 9.2 Million CNY | -69.2% |
| 2017 FY | 75.66 Million CNY | 12.77% |
| 2017 Q1 | 12.82 Million CNY | -18.51% |
| 2017 Q3 | 11.2 Million CNY | -57.34% |
| 2017 Q4 | 24.48 Million CNY | 118.62% |
| 2017 Q2 | 26.25 Million CNY | 104.65% |
| 2016 Q3 | 15.74 Million CNY | -9.58% |
| 2016 FY | 67.09 Million CNY | 62.79% |
| 2016 Q1 | 17.41 Million CNY | 77.05% |
| 2016 Q4 | 15.74 Million CNY | 0.0% |
| 2016 Q2 | 17.41 Million CNY | 0.0% |
| 2015 Q2 | 10.38 Million CNY | -0.0% |
| 2015 Q4 | 9.83 Million CNY | 0.0% |
| 2015 FY | 41.21 Million CNY | 85.12% |
| 2015 Q1 | 10.38 Million CNY | 49.93% |
| 2015 Q3 | 9.83 Million CNY | -5.33% |
| 2014 Q1 | 4.09 Million CNY | 36.69% |
| 2014 Q3 | 6.92 Million CNY | 69.39% |
| 2014 Q4 | 6.92 Million CNY | 0.0% |
| 2014 Q2 | 4.09 Million CNY | -0.0% |
| 2014 FY | 22.26 Million CNY | 167.81% |
| 2013 Q4 | 2.99 Million CNY | 0.0% |
| 2013 Q2 | 1.19 Million CNY | -0.0% |
| 2013 Q3 | 2.99 Million CNY | 151.15% |
| 2013 FY | 8.31 Million CNY | 552.04% |
| 2013 Q1 | 1.19 Million CNY | 0.0% |
| 2012 FY | 1.27 Million CNY | 621.45% |
| 2011 FY | -244.51 Thousand CNY | 0.0% |